WARNING: THIS TEST DOES NOT EVALUATE DRUG SAFETY OR PURITY
The Rapid Response™ Benzodiazepine Test Strip (Liquid / Powder) is a rapid visual immunoassay for the qualitative, presumptive detection of benzodiazepine in suspicious substances (liquids or powders) at the cut-off concentration of 300 ng/mL. Easy to use with detailed instructions for testing both liquid and powder samples. For forensic use only. Not an IVD.
WARNING: THIS TEST DOES NOT EVALUATE DRUG SAFETY OR PURITY
The Rapid Response™ Benzodiazepine Test Strip (Liquid / Powder) is a rapid visual immunoassay for the qualitative, presumptive detection of benzodiazepine in suspicious substances (liquids or powders) at the cut-off concentration of 300 ng/mL. Easy to use with detailed instructions for testing both liquid and powder samples. For forensic use only. Not an IVD.
Easy to use with detailed instructions
Individually packed strips for easy distribution
Detects Benzodiazepine in concentrations at and above 300 ng/mL
Instant Results*
For Liquid or Powder samples
Results interpretation printed on every pouch
Benzodiazepines are medications that are frequently prescribed for the symptomatic treatment of anxiety and sleep disorders. They produce their effects via specific receptors involving a neurochemical called gamma aminobutyric acid (GABA). Risk of physical dependence increases if Benzodiazepines are taken regularly (e.g., daily) for more than a few months, especially at higher than normal doses. Stopping abruptly can bring on such symptoms as trouble sleeping, gastrointestinal upset, feeling unwell, loss of appetite, sweating, trembling, weakness, anxiety, and changes in perception. The detection period for the Benzodiazepines in the urine is 3-7 days.
Please refer to the product insert for more details.
Public Health Ontario's review highlights the positive impact of drug checking test strips, indicating potential for overdose reduction and safer drug use. Read the study here Public Health Ontario Rapid Review.
Benzodiazepines are a controlled class of molecules which promote the binding of gamma-aminobutyric acid (GABA) to GABAA receptors in the body, resulting in reduced excitability of neurons and producing a calming effect on the brain.1 Due to the effects of benzodiazepines, they have been prescribed for a variety of uses, including to treat anxiety, insomnia, and muscle spasms.1,2 Xanax (alprazolam), Valium (diazepam), Halcion (triazolam), Ativan (lorazepam), and Klonopin (clonazepam) are currently among the most commonly prescribed pharmaceutical benzodiazepines.3
Benzodiazepine toxicity is often associated with central nervous system depression, such as slurred speech and loss of coordination; it is rare for vital processes, like respiration, to be severely depressed in cases of mono-substance benzodiazepine toxicity.9 However, benzodiazepines are often used with other drugs,7,8 such as opioids, and presents a heightened toxic effect in these situations. In such cases, benzodiazepines have been observed to significantly compound respiratory depression, a leading cause of overdose.2,9
- Griffin III, C. E. et al. The Ochsner Journal 2013.
- Schmitz, A. Ment Health Clin 2016.
- United States Drug Enforcement Administration. Drug Fact Sheet: Benzodiazepines 2020.
- Blakey, K. et al. Drug Test Anal 2021.
- Jurásek, B. et al. Int J Clin Pract. 2020.
- Tobias, S. et al. Drug Alc Dep 2020.
- Centre on Drug Policy Evaluation. Toronto’s increasingly unpredictable and toxic unregulated opioid supply 2023.
- Substance Abuse and Mental Health Services Administration. The TEDS Report: Admissions Reporting Benzodiazepine and Narcotic Pain Reliever Abuse at Treatment Entry 2012.
- British Columbia Centre on Substance Use Drug Checking in British Columbia 2023.
- Nation Library of Medicine Benzodiazepine Toxicity 2023.
- Canadian Centre on Substance Use and Addiction Prescription Opioids (Canadian Drug Summary) 2022.
* A negative result can be interpreted as soon as both the test (T) and control (C) lines appear. A positive result can be interpreted once the control line has appeared and the background has cleared to white, typically by 60 seconds. Do not read results after 10 minutes.
- The test device is NOT intended to determine the purity, composition, or if the substance being examined is safe to use.
- A positive or negative test result is NOT an indication that the substance being examined is safe to use. Many factors come into play when examining the samples, including but not limited to mixture of multiple substances, solubility, and pH of the sample.
- BTNX Inc. does not encourage the use, supply, or production of illegal drugs or controlled substances in any way. The device is intended for harm reduction purposes. Follow the advice of your local harm reduction or public health agency.
- There is a possibility that technical or procedural errors as well as other substances and factors may interfere with the Rapid Response™ Benzodiazepine Test Strip (Liquid / Powder) and cause false results.
- A positive result indicates the presence of benzodiazepine only and does not indicate quantity.
- A negative result does not at any time rule out the presence of benzodiazepine, as they may be present below the minimum detection level of the test.
- Please note that certain products may only be available in specific regions; kindly consult with a sales representative for further information regarding product availability.
- The information provided on this website is for educational purposes only and should not be construed as medical advice. Always consult with a qualified healthcare professional regarding any medical concerns or conditions.
- Our products are intended for use as specified in the product documentation. It is important to carefully read and follow all instructions provided with the product.